Angiotensin II (3-8), human

Angiotensin II (3-8), human is a less effective agonist at the angiotensin AT1 receptor.

Designed for biological research and industrial applications, not intended for individual clinical or medical purposes.
Angiotensin II (3-8), human(CAS 12676-15-2)

CAT No: R1201

CAS No:12676-15-2

Synonyms/Alias:Angiotensin IV;12676-15-2;23025-68-5;Angiotensin II (3-8), human;Human angiotensin IV;Nle-angiv;VAL-TYR-ILE-HIS-PRO-PHE;Ile3-angiotensin IV;Huamn angiotensin (3-8);1-De-asp-2-de-arg-5-ile-angiotensin II;(Ile5)-angiotensin II (3-8);(3-8)-5-Isoleucine-angiotensin II;Human angiotensin hexapeptide (3-8);(2S)-2-[[(2S)-1-[(2S)-2-[[(2S,3S)-2-[[(2S)-2-[[(2S)-2-amino-3-methylbutanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-3-methylpentanoyl]amino]-3-(1H-imidazol-5-yl)propanoyl]pyrrolidine-2-carbonyl]amino]-3-phenylpropanoic acid;angiotensin II, des-Asp(1)-des-Arg(2)-Ile(5)-;(Des(Asp1,Arg2)-Ile5)angiotensin II;(Isoleucine5)-angiotensin II hexapeptide;3-L-isoleucine-Angiotensin IV;CHEMBL261120;5-Isoleucine-angiotensin II 3-8-hexapeptide;Angiotensin II, des-aspartyl(1)-des-arginyl(2)-isoleucine(5)-;Angiotensin IV, 3-L-isoleucine-;AT II (3-8);Angiotensin IV trifluoroacetate salt;Alanine, 3-phenyl-N-(1-(N-(N-(N-valyltyrosyl)isoleucyl)histidyl)prolyl)-;Angiotensin II, 1-de-L-aspartic acid-2-de-L-arginine-5-L-isoleucine-;Angiotensin II (3-8);Alanine, 3-phenyl-N-(1-(N-(N-(N-L-valyl-L-tyrosyl)-L-isoleucyl)-L-histidyl)-L-prolyl)-;(2S)-2-{[(2S)-1-[(2S)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-3-(4-hydroxyphenyl)propanamido]-3-methylpentanamido]-3-(1H-imidazol-5-yl)propanoyl]pyrrolidin-2-yl]formamido}-3-phenylpropanoic acid;Ang IV;MLS000069773;Angiotensin II, 1-des-asn-2-arg;(2S)-2-((((2S)-1-((2S)-2-(((2S,3S)-2-(((2S)-2-(((2S)-2-amino-1-hydroxy-3-methylbutylidene)amino)-1-hydroxy-3-(4-hydroxyphenyl)propylidene)amino)-1-hydroxy-3-methylpentylidene)amino)-3-(1H-imidazol-5-yl)propanoyl)pyrrolidin-2-yl)(hydroxy)methylidene)amino)-3-phenylpropanoate;(2S)-2-(((2S)-1-((2S)-2-((2S,3S)-2-((2S)-2-((2S)-2-amino-3-methylbutanamido)-3-(4-hydroxyphenyl)propanamido)-3-methylpentanamido)-3-(1H-imidazol-5-yl)propanoyl)pyrrolidin-2-yl)formamido)-3-phenylpropanoic acid;(2S)-2-({[(2S)-1-[(2S)-2-{[(2S,3S)-2-{[(2S)-2-{[(2S)-2-amino-1-hydroxy-3-methylbutylidene]amino}-1-hydroxy-3-(4-hydroxyphenyl)propylidene]amino}-1-hydroxy-3-methylpentylidene]amino}-3-(1H-imidazol-5-yl)propanoyl]pyrrolidin-2-yl](hydroxy)methylidene}amino)-3-phenylpropanoate;MFCD00167496;(A)II(3-8);cid_123814;GTPL5368;SCHEMBL4322236;BDBM85550;CHEBI:80127;DTXSID701347717;HMS2232C15;1-De-L-aspartic -2-de-L-arginine-5-L-isoleucineangiotensin II;HY-P1515;AKOS040758825;NCGC00167590-02;DA-50481;FA110283;SMR000058913;CAS_12676-15-2;CS-0044614;G83766;H-Val-Tyr-Ile-His-Pro-Phe-OH; H-VYIHPF-OH;Q66087802;Angiotensin I/II (3-8) (H-Val-Tyr-Ile-His-Pro-Phe-OH);1-De-L-aspartic-2-de-L-arginine-5-L-isoleucineangiotensin II;Angiotensin IV trifluoroacetate salt, >=95% (HPLC), powder;valyl-l-tyrosyl-l-isoleucyl-l-histidyl-l-prolyl-l-phenylalanin;(2S)-2-{[(2S)-1-[(2S)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-AMINO-3-METHYLBUTANAMIDO]-3-(4-HYDROXYPHENYL)PROPANAMIDO]-3-METHYLPENTANAMIDO]-3-(1H-IMIDAZOL-4-YL)PROPANOYL]PYRROLIDIN-2-YL]FORMAMIDO}-3-PHENYLPROPANOIC ACID;(S)-2-((S)-1-((S)-2-((2S,3S)-2-((S)-2-((S)-2-amino-3-methylbutanamido)-3-(4-hydroxyphenyl)propanamido)-3-methylpentanamido)-3-(1H-imidazol-4-yl)propanoyl)pyrrolidine-2-carboxamido)-3-phenylpropanoic acid;

Custom Peptide Synthesis
cGMP Peptide
  • Registration of APIs
  • CMC information required for an IND
  • IND and NDA support
  • Drug master files (DMF) filing
M.F/Formula
C40H54N8O8
M.W/Mr.
774.9
Sequence
One Letter Code:VYIHPF
Three Letter Code:H-Val-Tyr-Ile-His-Pro-Phe-OH
Source#
Synthetic
InChI
InChI=1S/C40H54N8O8/c1-5-24(4)34(47-35(50)29(44-37(52)33(41)23(2)3)18-26-13-15-28(49)16-14-26)38(53)45-30(20-27-21-42-22-43-27)39(54)48-17-9-12-32(48)36(51)46-31(40(55)56)19-25-10-7-6-8-11-25/h6-8,10-11,13-16,21-24,29-34,49H,5,9,12,17-20,41H2,1-4H3,(H,42,43)(H,44,52)(H,45,53)(H,46,51)(H,47,50)(H,55,56)/t24-,29-,30-,31-,32-,33-,34-/m0/s1
InChI Key
QSBGWDDCOJYQGY-KOQODJNWSA-N

Useful Tools

Peptide Calculator

Abbreviation List

Peptide Glossary

If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.

Featured Services
Peptide Modification ServicesEpitope Mapping ServicesPeptide Analysis ServicesPeptide Synthesis ServicesPeptide Nucleic Acids SynthesisCustom Conjugation ServicePeptide CDMOcGMP Peptide Service
Hot Products
About us

Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.

From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.

Our Customers